Skip to main content
Caplight Logo









Cellistic

Cellistic

Private
Mont-Saint-GuibertHealthcare & Life Scienceshttps://www.cellistic.com/

Last Round

Corporate Funding

Nov 16, 2021

Total Funding Raised

$60M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cellistic is a biotechnology company that provides contract development and manufacturing organization (CDMO) services specializing in the process development and manufacturing of cell therapies based on human induced pluripotent stem cell (iPSC) technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMOiPSCcell therapy manufacturingbioprocess engineeringinduced pluripotent stem cellcontract developmentGMP manufacturingcell line developmentbiotech manufacturinganalytical developmentgene editingbioprocessingclinical-grade cellscell therapy scale-upbiotech CDMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellistic Comparables

Compare Cellistic with similar companies based on industry and business-model similarity.

Cellistic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RoslinCT
81%
Cellab CDMO
79%
I Peace, Inc.
79%

Cellistic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 16, 2021

Key People

Founding team and executive leadership

Stefan Braam

President and CTO

Executive Team

Marc Lourtie

Group CFO

Executive Team

Cellistic Investors

Notable investors and investment history

Cellistic investors
InvestorRounds
Biospring PartnersCorporate Funding
KinicitiCorporate Funding
Welsh, Carson, Anderson & StoweCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 57% MoM to 5.3K.

  • Nov 8, 2025

    Monthly visitors increased 88% MoM.

Cellistic Filings

Explore SEC and related filing metadata, where available.

Cellistic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellistic's valuation, stock price, and market status.

Is Cellistic a public or private company?

Cellistic is a private company.

What is the current stock price of Cellistic?

Cellistic is a private company with no public stock price. Caplight tracks Cellistic's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Cellistic worth (valuation)?

Valuation information for Cellistic is not publicly available.

Can I buy Cellistic stock?

Cellistic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellistic's last funding round?

Cellistic's most recent funding round was Corporate Funding on November 16, 2021.

Who are the main investors in Cellistic?

Key investors in Cellistic include Kiniciti.

Will Cellistic IPO soon?

No public IPO plans have been announced for Cellistic.

How can I track Cellistic secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellistic's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMont-Saint-Guibert
Employee Range74
Year Founded2022
Last FundingNov 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?